Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

XGN
Exagen Inc. Common Stock
stock NASDAQ

At Close
May 11, 2026 3:59:47 PM EDT
3.99USD+35.254%(+1.04)6,242,885
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 11, 2026 9:29:17 AM EDT
3.37USD+14.237%(+0.42)937,350
After-hours
May 11, 2026 4:57:30 PM EDT
3.96USD-0.634%(-0.03)49,318
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 9, 2022
12:02PM EST  Exagen and Queen Mary University of London Announced Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection   Benzinga
12:00PM EST  Exagen Inc. and Queen Mary University of London Announce Exclusive   GlobeNewswire Inc
Dec 27, 2021
06:18AM EST  Stonepine Capital Management, LLC Reported 5.2% Stake in Exagen in 13G Filing   Benzinga
Nov 17, 2021
04:05PM EST  Exagen Inc. to Participate in the Piper Sandler   GlobeNewswire Inc
Nov 11, 2021
04:34AM EST  Keybanc Maintains Overweight on Exagen, Lowers Price Target to $30   Benzinga
Nov 10, 2021
05:37PM EST  Exagen: Q3 Earnings Insights   Benzinga
05:33PM EST  Exagen Q3 EPS $(0.42) Beats $(0.46) Estimate, Sales $12.25M Beat $12.13M Estimate; Reaffirms FY21 Sales Guidance $47M-$49M   Benzinga
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Oct 27, 2021
04:05PM EDT  Exagen to Announce Third Quarter 2021 Financial Results on   GlobeNewswire Inc
08:25AM EDT  Exagen Inc.(Nasdaq: XGN),a leading provider of autoimmune testing solutions, announced today that AVISE CTD and AVISE Lupus are a contracted covered service with Inland Empire Health Plan (IEHP), providing enhanced care to over 1.4 million members. The agreement also makes AVISE diagnostic testing available as an in-network benefit.   GlobeNewswire Inc
Oct 25, 2021
08:25AM EDT  Exagen Inc. Announces $27.2 Million Debt Refinancing   GlobeNewswire Inc
Oct 21, 2021
04:05PM EDT  Exagen Inc.(Nasdaq: XGN),a leading provider of autoimmune testing solutions, announced today it will be presenting new scientific research at the American College of Rheumatologys (ACR) virtual annual meeting, ACR Convergence 2021. The event is being held online from November 6-9, 2021.   GlobeNewswire Inc
Sep 14, 2021
11:18AM EDT  Looking Into Exagen's Return On Capital Employed   Benzinga
Sep 13, 2021
04:15PM EDT  Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual   GlobeNewswire Inc
Aug 10, 2021
11:10AM EDT  Shares of autoimmune testing solutions provider Exagen Inc. (XGN) are surging more than 24% Tuesday morning after reporting better-than-expected second-quarter results. The company also reaffirmed its full-year revenue outlook.   RTTNews
Aug 9, 2021
05:42PM EDT  Exagen Sees FY21 Revs $47M-$49M   Benzinga
05:42PM EDT  Exagen: Q2 Earnings Insights   Benzinga
04:47PM EDT  Exagen Q2 EPS $(0.38) Beats $(0.44) Estimate, Sales $12.80M Beat $11.48M Estimate   Benzinga
04:05PM EDT  Exagen Inc. (Nasdaq: XGN),a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June30, 2021.   GlobeNewswire Inc
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Jul 30, 2021
08:25AM EDT  Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the addition of Ms. Ana Hooker as an additional independent member to its Board of Directors, effective July 29, 2021.   GlobeNewswire Inc
Jul 29, 2021
08:25AM EDT  Exagen Inc. to Participate in the Canaccord Genuity 41st Annual   GlobeNewswire Inc
Jul 26, 2021
04:06PM EDT  Exagen to Announce Second Quarter 2021 Financial Results on August   GlobeNewswire Inc
Jul 13, 2021
04:11PM EDT  Exagen Announces AVISE Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions   Benzinga
04:05PM EDT  AVISE Lupus Test Demonstrates Statistically   GlobeNewswire Inc
Jun 18, 2021
10:17AM EDT  Return On Capital Employed Overview: Exagen   Benzinga
08:29AM EDT  Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the companys stockholders approved the election of Mr. Frank Stokes as an additional independent member to its Board of Directors at the Annual Meeting held on June 17, 2021. Mr. Stokes will also serve as Chair of the Audit Committee.   GlobeNewswire Inc
Jun 3, 2021
11:06AM EDT  Exagen: Return On Capital Employed Insights   Benzinga
May 24, 2021
04:05PM EDT  Exagen Inc.(Nasdaq: XGN),a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 41st Annual Growth Stock Conference which takes place June 1-3, 2021. Ron Rocca, Exagens President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will participate in a virtual fireside chat on Wednesday, June 2 at 11:20 AM EDT.   GlobeNewswire Inc
May 11, 2021
04:38PM EDT  Exagen: Q1 Earnings Insights   Benzinga
04:37PM EDT  Exagen Sees FY21 $47M-$49M Vs $47.99M Est   Benzinga
04:33PM EDT  Exagen Q1 EPS $(0.48) Misses $(0.47) Estimate, Sales $10.59M Beat $10.45M Estimate   Benzinga
04:05PM EDT  Quarterly Records: AVISE CTD Volumes, Ordering Healthcare Providers and Adopters   GlobeNewswire Inc
12:47PM EDT  Earnings Scheduled For May 11, 2021   Benzinga
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
04:14AM EDT  Earnings Scheduled For May 11, 2021   Benzinga
May 4, 2021
04:53PM EDT  Exagen Reports Collaboration With Allegheny Health Network Research, AHN Autoimmunity Institute To Develop Novel Patented Biomarkers Into Clinical Diagnostic Tests   Benzinga
04:05PM EDT  Exagen Inc., Allegheny Health Network Research Institute and AHN   GlobeNewswire Inc
May 3, 2021
08:25AM EDT  Exagen Inc.(Nasdaq: XGN),a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of awareness initiatives and educational tools highlighting the importance of an accurate and timely diagnosis and patient monitoring for Systemic Lupus Erythematosus (SLE).   GlobeNewswire Inc
Apr 27, 2021
04:05PM EDT  Exagen to Announce First Quarter 2021 Financial Results on May 11,   GlobeNewswire Inc
Apr 15, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021   Benzinga
07:17AM EDT  Canaccord Genuity Initiates Coverage On Exagen with Buy Rating, Announces Price Target of $25   Benzinga
Mar 29, 2021
08:28AM EDT  Exagen Announces Study On The Long-Term Effects Of COVID-19 Infection In Development Of Autoimmune Diseases   Benzinga
08:25AM EDT  Exagen Inc. Announces Study on the Long-Term Effects of COVID-19   GlobeNewswire Inc
Mar 25, 2021
04:16PM EDT  Exagen Inc. Announces Closing of Public Offering of Common Stock,   GlobeNewswire Inc
Mar 23, 2021
08:18AM EDT  The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO   Benzinga
Mar 22, 2021
10:45PM EDT  Exagen Prices Underwritten Public Offering Of 3.70 Mln Shares At $16.25/shr   RTTNews
10:01PM EDT  Exagen Inc. Announces Pricing of Public Offering of Common Stock   GlobeNewswire Inc
04:06PM EDT  Exagen Reports Offering Of Common Stock, No Size Disclosed   Benzinga
04:05PM EDT  Exagen Inc. Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
Mar 16, 2021
04:14PM EDT  Exagen Sees FY21 Sales $47M-$49M Vs. $52.64M Est.   Benzinga
04:13PM EDT  Exagen Q4 EPS $(0.27) Beats $(0.40) Estimate, Sales $12.70M Beat $10.76M Estimate   Benzinga
04:05PM EDT  Exagen Inc. (Nasdaq: XGN),a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year ended December 31, 2020.   GlobeNewswire Inc
08:17AM EDT  The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study   Benzinga
04:46AM EDT  Earnings Scheduled For March 16, 2021   Benzinga
Mar 14, 2021
08:14AM EDT  Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations   Benzinga
Mar 3, 2021
07:46AM EST  The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study   Benzinga
Mar 2, 2021
08:00AM EST  Exagen to Announce Fourth Quarter and Full Year Financial Results   GlobeNewswire Inc
04:45AM EST  KeyBanc Maintains Overweight on Exagen, Raises Price Target to $33   Benzinga
Feb 22, 2021
04:05PM EST  Exagen Inc.(Nasdaq: XGN),a leading autoimmune organization, today announced its participation in the Cowen 41st Annual Health Care Conference which takes place March 1-4, 2021. Ron Rocca, Exagens President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will participate in a virtual fireside chat on Wednesday, March 3 at 4:00 pm EST.   GlobeNewswire Inc
Feb 8, 2021
09:51AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
Feb 3, 2021
04:05PM EST  Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life   GlobeNewswire Inc
Feb 1, 2021
09:47AM EST  5 Value Stocks In The Healthcare Sector   Benzinga
Jan 22, 2021
07:22AM EST  The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa   Benzinga
Jan 21, 2021
04:09PM EST  Exagen Reports Partnership With Boston's Tufts Medical Center To Offer AVISE Testing As In-Network Benefit For Patients Suffering From Debilitating Autoimmune Diseases, No Terms Disclosed   Benzinga
04:05PM EST  Exagen Inc.(Nasdaq: XGN),an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that all AVISE test offerings (CTD, Lupus, SLE Prognostic, SLE Monitor, APS, Vasculitis AAV, MTX, and HCQ) are now a contracted in-network service with Tufts Medical Center, an internationally-respected academic medical center.   GlobeNewswire Inc
Jan 10, 2021
06:00PM EST  Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results   GlobeNewswire Inc
Jan 5, 2021
04:05PM EST  Exagen Inc. To Participate in 2021 ICR Conference   GlobeNewswire Inc
Jan 4, 2021
04:07PM EST  Exagen Inc. Partners with Oregon's St. Charles Health System to Offer AVISE Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases   Benzinga
04:05PM EST  Exagen Inc.(Nasdaq: XGN),an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that all AVISE test offerings (CTD, Lupus, SLE Prognostic, SLE Monitor, APS, Vasculitis AAV, MTX, and HCQ) are a contracted in-network service with St. Charles Health System, the largest provider of medical care in Central Oregon.   GlobeNewswire Inc
Dec 28, 2020
04:18PM EST  Exagen 8-K Shows Co., Janssen Biotech Entered Amendment To Co-Promotion Deal For Average Baseline Of Total Prescribed Units Of SIMPONI To ~28,750/Qtr.   Benzinga
Dec 21, 2020
09:54AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
Nov 18, 2020
04:05PM EST  Exagen Inc.(Nasdaq: XGN),an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following December investor conferences:   GlobeNewswire Inc
Nov 16, 2020
08:28AM EST  Exagen Extends Collaboration Deal With GlaxoSmithKline To Raise Awareness Of Importance Of Timely Diagnosis Of Systemic Lupus Erythematosus   Benzinga
08:25AM EST  Exagen and GSK partner for 4th straight year, driving greater   GlobeNewswire Inc
Nov 10, 2020
05:25PM EST  Exagen Inc Files For Mixed Shelf Of Up To $150M   Benzinga
05:03PM EST  Recap: Exagen Q3 Earnings   Benzinga
04:25PM EST  Exagen Q3 EPS $(0.34) Beats $(0.48) Estimate, Sales $10.80M Beat $8.88M Estimate   Benzinga
04:05PM EST  Exagen Inc. (Nasdaq: XGN),an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported financial results for the quarter ended September30, 2020.   GlobeNewswire Inc
Nov 9, 2020
08:25AM EST  Exagen Inc.(Nasdaq: XGN),an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following November investor conferences.   GlobeNewswire Inc
Nov 2, 2020
08:25AM EST  Exagen Announces Study To Evaluate Emergence Of Autoimmune Diseases After COVID-19 Infection   Benzinga
08:25AM EST  Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune   GlobeNewswire Inc
Oct 27, 2020
04:05PM EDT  Exagen to Announce Third Quarter Financial Results on November 10,   GlobeNewswire Inc
Oct 21, 2020
04:10PM EDT  Exagen Showcases Six Scientific Presentations At ACR's First Virtual Annual Meeting Nov. 5-9, 2020   Benzinga
04:05PM EDT  Exagen Inc.(Nasdaq: XGN),an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced todayitwill be presenting new scientific research at the American College of Rheumatologys (ACR) first virtual annual meeting, ACR Convergence 2020. The event is being held online from November 5-9, 2020.   GlobeNewswire Inc
Oct 12, 2020
04:06PM EDT  Exagen Reports New Data Demonstrates Economic Benefit Of Co's AVISE Lupus Test For Payors   Benzinga
04:05PM EDT  New Data Demonstrates Economic Benefit of   GlobeNewswire Inc
Oct 8, 2020
05:43AM EDT  BTIG Initiates Coverage On Exagen with Buy Rating, Announces Price Target of $18   Benzinga
Sep 29, 2020
08:25AM EDT  Exagen Announces Agreement With Provider Network Of America Expanding Access For AVISE Tests To 8M Members   Benzinga
08:25AM EDT  Exagen Inc. Announces Agreement with Provider Network of America   GlobeNewswire Inc
Sep 23, 2020
04:15PM EDT  Exagen Appoints Wendy Johnson To Board Of Directors   RTTNews
04:10PM EDT  Exagen Inc. (Nasdaq: XGN),an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, is proud to announce the addition of Ms. Wendy S. Johnson as an additional independent member to its Board of Directors, effective October 1, 2020. Ms. Johnson will also serve on the Audit Committee.   GlobeNewswire Inc
Sep 21, 2020
08:26AM EDT  Exagen Launches Test To Aid In The Detection Of ANCA-Associated Vasculitis   Benzinga
08:25AM EDT  Exagen Inc.(Nasdaq: XGN),an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced the launch of AVISE Vasculitis AAV, a new testing panel of individual analytes designed to provide physicians with rapid and reliable results in the assessment and monitoring of ANCA-associated vasculitis (AAV).   GlobeNewswire Inc
Sep 3, 2020
04:05PM EDT  Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global   GlobeNewswire Inc
Aug 3, 2020
04:24PM EDT  Exagen Reports Collaboration With Hospital For Special Surgery In New York City For Antiphospholipid Syndrome, No Terms Disclosed   Benzinga
04:05PM EDT  Exagen Inc. Announces a Collaboration with Hospital for Special   GlobeNewswire Inc
Jul 28, 2020
07:21AM EDT  Exagen Q2 EPS $(0.27) Beats $(0.76) Estimate, Sales $8.95M Beat $4.68M Estimate   Benzinga
07:00AM EDT  Testing Experiencing Monthly Sequential ImprovementRecord Gross Margins of 63%   GlobeNewswire Inc
04:05AM EDT  Earnings Scheduled For July 28, 2020   Benzinga
Jul 27, 2020
04:05PM EDT  Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East   GlobeNewswire Inc
Jul 16, 2020
10:46AM EDT  Exagen to Announce Second Quarter Financial Results on July 28, 2020   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC